Is Rollins, Inc. (ROL) a Keeper?

Rollins, Inc. (NYSE:ROL) went up by 0.90% from its latest closing price compared to the recent 1-year high of $57.16. The company’s stock price has collected 1.73% of gains in the last five trading sessions. MarketWatch.com reported on 09/03/20 that These 74 stocks in the S&P 500 hit all-time records on Wednesday

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is It Worth Investing in Rollins, Inc. (NYSE :ROL) Right Now?

Rollins, Inc. (NYSE:ROL) scored a price-to-earnings ratio above its average ratio, recording 84.41 x from its present earnings ratio. Plus, the 36-month beta value for ROL is at 0.49. Opinions of the stock are interesting as 1 analysts out of 4 who provided ratings for Rollins, Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”

The average price from analysts is $47.67, which is -$7.11 below the current price. ROL currently public float of 159.85M and currently shorts hold a 5.22% ratio of that float. Today, the average trading volume of ROL was 966.00K shares.

ROL’s Market Performance

ROL stocks went up by 1.73% for the week, with a monthly jump of 0.09% and a quarterly performance of 29.29%, while its annual performance rate touched 58.35%. The volatility ratio for the week stands at 2.08% while the volatility levels for the past 30 days are set at 1.93% for Rollins, Inc.. The simple moving average for the period of the last 20 days is -0.26% for ROL stocks with a simple moving average of 32.35% for the last 200 days.

Analysts’ Opinion of ROL

Many brokerage firms have already submitted their reports for ROL stocks, with Jefferies repeating the rating for ROL by listing it as a “Hold.” The predicted price for ROL in the upcoming period, according to Jefferies is $65 based on the research report published on November 22nd of the previous year 2019.

Stifel, on the other hand, stated in their research note that they expect to see ROL reach a price target of $34, previously predicting the value of $28.50. The rating they have provided for ROL stocks is “Hold” according to the report published on November 6th, 2019.

RBC Capital Mkts gave a rating of “Sector Perform” to ROL, setting the target price at $34 in the report published on October 8th of the previous year.

ROL Trading at 5.70% from the 50-Day Moving Average

After a stumble in the market that brought ROL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -4.17% of loss for the given period.

Volatility was left at 1.93%, however, over the last 30 days, the volatility rate increased by 2.08%, as shares sank -0.16% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +28.14% upper at present.

During the last 5 trading sessions, ROL rose by +1.73%, which changed the moving average for the period of 200-days by +52.68% in comparison to the 20-day moving average, which settled at $54.92. In addition, Rollins, Inc. saw 65.20% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ROL starting from Wilson John F, who sold 26,000 shares at the price of $39.76 back on Feb 12. After this action, Wilson John F now owns 517,167 shares of Rollins, Inc., valued at $1,033,760 using the latest closing price.

Paul Edward Northen, the Senior VP, CFO & Treasurer of Rollins, Inc., bought 5 shares at $35.05 during a trade that took place back on Jan 14, which means that Paul Edward Northen is holding 5 shares at $175 based on the most recent closing price.

Stock Fundamentals for ROL

Current profitability levels for the company are sitting at:

  • +15.75 for the present operating margin
  • +46.68 for the gross margin

The net margin for Rollins, Inc. stands at +10.09. The total capital return value is set at 31.41, while invested capital returns managed to touch 20.94. Equity return is now at value 26.00, with 12.00 for asset returns.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Based on Rollins, Inc. (ROL), the company’s capital structure generated 60.47 points at debt to equity in total, while total debt to capital is 37.68. Total debt to assets is 28.28, with long-term debt to equity ratio resting at 47.97. Finally, the long-term debt to capital ratio is 50.83.

When we switch over and look at the enterprise to sales, we see a ratio of 5.59, with the company’s debt to enterprise value settled at 0.04. The receivables turnover for the company is 15.07 and the total asset turnover is 1.39. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.76.

Related Articles

Buy or Sell XpresSpa Group Inc. (XSPA) Stock Now | Don’t Try to Be a Top Gun

XpresSpa Group Inc. (NASDAQ:XSPA) went up by 7.26% from its latest closing price compared to the recent 1-year high of $8.82. Press Release reported...

Newmont Corporation (NEM) and the Battle of Fundamentals vs. Technicals

Newmont Corporation (NYSE:NEM) went down by -0.03% from its latest closing price compared to the recent 1-year high of $72.22. The company’s stock price...

The Chart for Guardion Health Sciences Inc. (GHSI) Is Flashing Mixed Signals

Guardion Health Sciences Inc. (NASDAQ:GHSI) went down by -6.24% from its latest closing price compared to the recent 1-year high of $0.95. The company’s...

Latest Posts

Buy or Sell XpresSpa Group Inc. (XSPA) Stock Now | Don’t Try to Be a Top Gun

XpresSpa Group Inc. (NASDAQ:XSPA) went up by 7.26% from its latest closing price compared to the recent 1-year high of $8.82. Press Release reported...

Newmont Corporation (NEM) and the Battle of Fundamentals vs. Technicals

Newmont Corporation (NYSE:NEM) went down by -0.03% from its latest closing price compared to the recent 1-year high of $72.22. The company’s stock price...

The Chart for Guardion Health Sciences Inc. (GHSI) Is Flashing Mixed Signals

Guardion Health Sciences Inc. (NASDAQ:GHSI) went down by -6.24% from its latest closing price compared to the recent 1-year high of $0.95. The company’s...

Here’s Our Rant About BioCryst Pharmaceuticals Inc. (BCRX)

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) went up by 6.12% from its latest closing price compared to the recent 1-year high of $6.29. The company’s stock...

Here is How Warren Buffer Would Trade HighPoint Resources Corporation (HPR)

HighPoint Resources Corporation (NYSE:HPR) went down by -1.24% from its latest closing price compared to the recent 1-year high of $1.98. The company’s stock...